Live
CellSTING signaling modulation by COPII cargo recognitionCellDevelopment of non-spatial grid-like neural codes tracks inference and intelligenceFierceBiotechCMR Surgical kicks off Versius Plus robot’s US commercial launchAgilentVanguard disaggregates holdings after realignment — Agilent (NYSE: A) - Stock TitanScience‘Resurrection plants’ bounce back after years of drought. Do they hold lessons for crops?Thermo FisherIs Thermo Fisher Scientific (TMO) one of the best conservative stocks to buy right now? - MSNEndpoints NewsBiopharma industry pushes back on FDA's 'America First' user fee proposalsEndpoints NewsRecordati says it's received a $12B+ takeover bidEndpoints NewsUCB picks Georgia for $2B biologics site; AbbVie exec visits ChinaEndpoints NewsNew tech, familiar problemsBioPharma DiveMerck’s deal for Terns sparks debate over a possible biotech bidding warFierceBiotechWave crashes after obesity trial tracks 1% dip in body weight over 6 months
Endpoints News Mar 26, 2026

UCB picks Georgia for $2B biologics site; AbbVie exec visits China

UCB picks Georgia for $2B biologics site; AbbVie exec visits China

Original
Body unavailable. Use the original source.

Directory

59 All